Publication
The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19
01 Ocak 2022
Makale
Özgün Makale
Authors
Atıf kopyala
D. T. DEMİRCİ (2022). The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19. *European Review for Medical and Pharmacological Sciences*, 26(22), 8612–8619. https://doi.org/10.26355/eurrev_202211_30398
Yayın bilgileri
Dergi
European Review for Medical and Pharmacological Sciences
Veri tabanı
SCI-Expanded
Cilt / Sayı
26 / 22
Sayfa
8612 – 8619
Keywords
Dergi: European Review for Medical and Pharmacological Sciences | Yıl: 2022 | Cilt/Sayı: 26/22 | Sayfa: 8612-8619 | DOI: 10.26355/eurrev_202211_30398 | Yazarlar: Karacaer Cengiz,SERT HAVVA,DEMİRCİ TANER,VARIM CEYHUN,kaya gülsüm,genç ahmet bilal,ÇEKİÇ DENİZ,ERGENÇ HASAN,YAYLACI SELÇUK,NALBANT AHMET,KAYA TEZCAN,DEMİRCİ AYŞE,ÖZTOP KENAN EVREN | Anahtar kelimeler: The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19
Other publications by authors
Other academic outputs by the same KKU authors — newest first.
İlgili yayınlar yükleniyor…
İlgili yayın bulunamadı.
UN Sustainable Development Goals
Goals linked to this publication